Search

Gerald S Rork

age ~78

from Lawrence, KS

Gerald Rork Phones & Addresses

  • 1213 1100 Rd, Laurence, KS 66047 • 785 842-9606
  • Lawrence, KS
  • Plainfield, NJ
  • 1213 N 1100 Rd, Laurence, KS 66047

Us Patents

  • Controlled Release Drug Suspension Delivery Device

    view source
  • US Patent:
    55828388, Dec 10, 1996
  • Filed:
    Dec 22, 1994
  • Appl. No.:
    8/363451
  • Inventors:
    Gerald S. Rork - Lawrence KS
    James D. Pipkin - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 924
    A61K 932
    A61K 936
  • US Classification:
    424472
  • Abstract:
    A device is disclosed for the controlled delivery of a beneficial agent, the device consisting of (i) a core comprising at least two layers, wherein at least one layer comprises a beneficial agent and a polymer which forms microscopic gel beads upon hydration and at least one layer which comprises a polymer which forms microscopic gel beads upon hydration; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of the microscopic gel beads.
  • Controlled Porosity Osmotic Pump

    view source
  • US Patent:
    48806315, Nov 14, 1989
  • Filed:
    Sep 24, 1987
  • Appl. No.:
    7/100665
  • Inventors:
    John L. Haslam - Lawrence KS
    Gerald S. Rork - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 3155
  • US Classification:
    424424
  • Abstract:
    The instant invention is directed to an osmotic pump, for the controlled release of diltiazem L-malate to an environment of use, said pump comprising: (A) a core which comprises a therapeutically effective amount of diltiazem L-malate and an effective buffering amount of sodium bitartrate surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. -14 cm. sup. 3 sec/g and a reflection coefficient of less than 0. 5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0. 1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.
  • Controlled Release Simvastatin Delivery Device

    view source
  • US Patent:
    58826823, Mar 16, 1999
  • Filed:
    Aug 1, 1997
  • Appl. No.:
    8/817129
  • Inventors:
    Gerald S. Rork - Lawrence KS
    James D. Pipkin - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 924
  • US Classification:
    424473
  • Abstract:
    Controlled delivery of a beneficial agent in a dispersion is provided using (i) a compressed core which contains the beneficial agent, a polymer which forms gelatinous microscopic particles upon hydration, and if desired, an agent to modulate the hydration; and (ii) a water insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of the dispersion. The release rate of the beneficial agent is a function of the number and size of the apertures in the coating.
  • Controlled Porosity Osmotic Pump

    view source
  • US Patent:
    49685074, Nov 6, 1990
  • Filed:
    Jul 15, 1987
  • Appl. No.:
    7/073781
  • Inventors:
    Gaylen M. Zentner - Lawrence KS
    Gerald S. Rork - Lawrence KS
    Kenneth J. Himmelstein - Irvine CA
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 964
  • US Classification:
    424465
  • Abstract:
    The instant invention is directed to an osmotic pump comprising: (A) at least one active agent surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. -14 cm. sup. 3 sec/g and a reflection coefficient of less than 1, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0. 1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.
  • Controlled Release Drug Dispersion Delivery Device

    view source
  • US Patent:
    53667387, Nov 22, 1994
  • Filed:
    Sep 8, 1993
  • Appl. No.:
    8/118836
  • Inventors:
    Gerald S. Rork - Lawrence KS
    James D. Pipkin - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 924
  • US Classification:
    424473
  • Abstract:
    A device for the controlled delivery of a beneficial agent as a gelatinous dispersion consisting of (i) a core which contains a beneficial agent, a polymer which forms gelatinous microscopic particles upon hydration and if desired an agent to modulate the hydration of the polymer; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of a dispersion comprising gelatinous microscopic particles.
  • Controlled Release Nifedipine Delivery Device

    view source
  • US Patent:
    55431542, Aug 6, 1996
  • Filed:
    Oct 21, 1994
  • Appl. No.:
    8/327083
  • Inventors:
    Gerald S. Rork - Lawrence KS
    James D. Pipkin - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 924
  • US Classification:
    424473
  • Abstract:
    A device for the controlled delivery of a beneficial agent as a gelatinous dispersion consisting of (i) a core which contains a beneficial agent, a polymer which forms gelatinous micoroscopic particles upon hydration and if desired an agent to modulate the hydration of the polymer; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of a disperson comprising gelatinous microscopic particles.
  • Multiparticulate Controlled Porosity Osmotic

    view source
  • US Patent:
    48512281, Jul 25, 1989
  • Filed:
    Jul 15, 1987
  • Appl. No.:
    7/073596
  • Inventors:
    Gaylen M. Zentner - Lawrence KS
    Kenneth J. Himmelstein - Irvine CA
    Gerald S. Rork - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 964
  • US Classification:
    424456
  • Abstract:
    The instant invention is directed to a multiparticulate osmotic pump, for the controlled release of a pharmaceutically active agent to an environment of use, said pump comprising: (I) a carrier medium which does not maintain its integrity in the environment of use; (II) a multiple of tiny osmotic pump elements each consisting essentially of: (A) a core comprises at least one pharmacologically active agent soluble in an external fluid, or a mixture of an agent having a limited solubility in the external fluid with an osmotically effective solute that is soluble in the fluid, which exhibit an osmotic pressure gradient across the wall against the external fluid surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. 14 cm. sup. 3 sec/g and a reflection coefficient of less than 0. 5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0.
  • Multiparticulate Controlled Porosity Osmotic Pump

    view source
  • US Patent:
    48866687, Dec 12, 1989
  • Filed:
    Sep 24, 1987
  • Appl. No.:
    7/100676
  • Inventors:
    John L. Haslam - Lawrence KS
    Gerald S. Rork - Lawrence KS
  • Assignee:
    Merck & Co., Inc. - Rahway NJ
  • International Classification:
    A61K 3155
  • US Classification:
    424424
  • Abstract:
    The instant invention is directed to a multiparticulate osmotic pump, for the controlled release of diltiazem L-malate to an environment of use, said pump comprising: (I) a carrier medium which does not maintain its integrity in the environment of use; (II) a multiple of tiny osmotic pump elements each comprising: (A) a core comprises diltiazem L-malate and an effective buffering amount of sodium bitartrate surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. -14 cm. sup. 3 sec/g and a reflection coefficient of less than 0. 5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0. 1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall, wherein the total amount of diltiazem L-malate in all of the osmotic pump elements is a therapeutically effective amount.

Youtube

Gerald Scarfe - 'Drawing Blood' documentary ...

A documentary about the artist, the highlight for me being his Royal F...

  • Duration:
    50m 48s

Gerhard Richter: 40 Years of Painting | Docum...

Described in Art Review as the world's most influential and expensive ...

  • Duration:
    13m 55s

BURNING DOWN THE ECONOMY - #TRADING #INVESTIN...

The Money Flow Trading System hard copy & eBook Getting Started with...

  • Duration:
    54m 41s

OIL TRADE BLOWING UP? - 12-5-22 - #TRADING #I...

The Money Flow Trading System hard copy & eBook Grab free eBook, "Yo...

  • Duration:
    49m 51s

OIL KEEPS PUSHING 10-6-22 - #TRADING #INVESTI...

SPECIAL TRADING MENTORSHIP OFFER - JOIN MFG TODAY RECEIVE FREE MONEY F...

  • Duration:
    40m 16s

Asymmetric Risk and Abundance

Text newgold to 888-685-0577 to get on my Thoughts of Abundance text ...

  • Duration:
    42m 50s

Get Report for Gerald S Rork from Lawrence, KS, age ~78
Control profile